TrialCancer medicine2023

Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous, non-small cell lung cancer: TORG (thoracic oncology research group) 1321.

Takashi Kasai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.